The advance could one day lead to a world in which transplants are no longer necessary to repair damaged organs, researchers said.
"We've been able to take MRI images of coronary arteries and 3-D images of embryonic hearts and 3-D bioprint them with unprecedented resolution and quality out of very soft materials like collagens, alginates and fibrins," said Adam Feinberg, an associate professor at Carnegie Mellon University.
"We should expect to see 3-D bioprinting continue to grow as an important tool for a large number of medical applications," said Jim Garrett, Dean of Carnegie Mellon's College of Engineering.
Printing each layer requires sturdy support from the layers below, so printing with soft materials like gels has been limited.
"The challenge with soft materials - think about something like Jello that we eat - is that they collapse under their own weight when 3-D printed in air," said Feinberg.
"So we developed a method of printing these soft materials inside a support bath material. Essentially, we print one gel inside of another gel, which allows us to accurately position the soft material as it's being printed, layer-by-layer," he said.
As a next step, the group is working towards incorporating real heart cells into these 3-D printed tissue structures, providing a scaffold to help form contractile muscle.
Bioprinting is a growing field, but to date, most 3-D bioprinters have cost over USD 100,000 and require specialised expertise to operate, limiting wider-spread adoption, researchers said.
The study was published in the journal Science Advances.
